IP Library Granted Patent US 7,256,279
Granted Patent B2
US 7,256,279 · App. 10/698,228 · Granted Aug 14, 2007

Protein having ribonucleotide reductase activity and DNA thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,256,279
App. No.
10/698,228
Granted
Aug 14, 2007
Kind
B2
Abstract

A protein having ribonucleotide reductase activity, DNA encoding the protein, antibodies to these and the like are disclosed. The protein, DNA and antibodies are useful in the prevention, treatment and diagnosis, etc. of cancer.

Claims (6)

1. An isolated nucleic acid molecule comprising a base sequence encoding a protein having the amino acid sequence set forth as SEQ ID NO: 1 and having ribonucleotide reductase activity.

2. The isolated nucleic acid molecule according to claim 1 , wherein the molecule is DNA.

3. The isolated nucleic acid molecule according to claim 2 , wherein the molecule comprises the base sequence set forth as SEQ ID NO: 2.

4. The isolated nucleic acid molecule according to claim 2 , wherein the molecule comprises the base sequence set forth as SEQ ID NO: 12.

5. A recombinant vector comprising the nucleic acid molecule according to claim 1 .

6. A pharmaceutical composition comprising the nucleic acid molecule according to claim 1 and a pharmaceutically acceptable carier.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2012
From: NAKAMURA, YUSUKE
To: ONCOTHERAPY SCIENCE, INC.
Reel/Frame 028382/0811 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2011
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: NAKAMURA, YUSUKE
Reel/Frame 026988/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2007
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 019013/0140 →